We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
MAXALT rizatriptan (as benzoate) 10mg wafer blister pack, Organon Pharma Pty Ltd, CON-869
Product name
MAXALT rizatriptan (as benzoate) 10mg wafer blister pack
Sponsor name
Organon Pharma Pty Ltd
Consent start
Consent no.
CON-869
Duration
The consent is effective for all batches of the products released from 24 September 2021 until 31 October 2023.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The product packaging does not conform with the requirement of Paragraph 8(1)(i)
of Therapeutic Goods Order No. 91 – Standard for labels of prescription and
related medicines in that the labels do not include the current sponsor details
(Organon Pharma Pty Ltd).
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines